Skip to main content
. 2017 Oct 23;113(3):545–563. doi: 10.1111/add.14012

Figure 4.

Figure 4

Impact of high‐coverage needle and syringe programmes (NSP) versus no/low coverage on hepatitis C virus (HCV) incidence from studies adjusted for confounders and by region. [Colour figure can be viewed at wileyonlinelibrary.com]